Accelerate Your Path to Market with Vernal’s Pre-GMP mRNA and LNP Development Expertise
The Pre-GMP (Good Manufacturing Practice) steps of an mRNA program set the stage and the probabilities of success for safe, effective, and compliant drug products. Vernal’s Pre-GMP mRNA and LNP development services streamline process development, optimize scalability, and ensure rigorous quality standards, enabling drug developers to navigate the complexities of regulatory requirements with confidence. By leveraging our expertise, you can identify and mitigate risks early, enhance product quality, and accelerate your journey to market—transforming innovative ideas into life-changing therapies faster and more efficiently than ever before.
Drug Developers can utilize our Pre-GMP mRNA and LNP development services at key stages, including Material Supply for Analytical Method Establishment and Qualification, Stability Studies to assess product performance under varying conditions, Non-GLP Toxicology Studies for potential early safety evaluations, and Pivotal Preclinical Studies to generate essential data for regulatory submissions and clinical trial preparation. Our services provide the solid foundation needed for a successful and efficient path to market.
Key Benefits
Access Pre-GMP mRNA & LNP Development Details
Request a Consultation
Next Steps: Your Request Made Easy
Comprehensive Pre-GMP Solutions for Effective mRNA Development and Drug Manufacturing
Process Development | Establishment (Potential Critical Process Parameters (pCPPs) at Target) Full Development (Design of Experiment (DoE)) |
GMP-Representative Manufacturing Process | Scalable Unit Operations Process Closure Animal Origin Free (AOF) Process Considerations Elevated Segregation Controls Primary Cell Bank Hold Time Demonstration |
Process Documentation | Preliminary Facility Fit (for Technology Transfer (TT) Projects) Raw Material Review Packets Process Description(s) Batch Records Process Closure Risk Assessment Project Specific Protocols Protocols for Production of Product for Good Laboratory Practice (GLP) Tox Studies Protocols for Production of E. Coli Primary Cell Banks |
Quality | Establish initial specifications for Drug Substance/Drug Product (DS/DP) from Target Product Profile/Quality Target Product Profile (TPP/QTPP) Creation of template Certificates of Analysis (CoA(s)) Method Establishment & Qualification |
Investigational New Drug (IND) Submission Support | Provision of Information for Submission Participation in Pre-IND Consultation Program |
High-Quality mRNA & LNP | Custom mRNA Manufacturing LNP-Formulated mRNA |
Start or Seamlessly Transfer Projects to Vernal
Begin your project with Vernal or seamlessly transfer your existing project to us and say
goodbye to constant delays in development, juggling multiple vendors, dealing with unclear
processes, and the persistent worry of sacrificing quality to meet deadlines.
It’s been very helpful to have a group that’s actually responsive and interested in trying out something, providing a continual effort to improve our mRNA.
Reason
Co-Founder & CEO, Repair Biotechnologies